Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Companion Diagnostics

John Schilling's Biography

John Schilling, Director & Advisor of Diagnostics, Eli Lilly & Co.

John Schilling, MBA, is a thirteen year employee of Eli Lilly & Co., who currently is Director – Advisor of Diagnostics. John is responsible for executing the global companion diagnostic strategy to enable the capabilities to deliver for the global drug teams across Lilly’s pharmaceutical business units. John’s prior responsibilities at Lilly have been as Global Marketing Director for pre-approved drug assets and the global Forteo and Evista brands. Prior to Eli Lilly, John has worked as Marketing Director for Bausch & Lomb’s pharmaceutical division representing the anti-allergy and dry eye products. He also was U.S. Brand Manager for AstraZeneca’s Prilosec brand. Prior to John’s pharmaceutical experience, he worked in the diagnostic industry for Abbott Laboratories Diagnostics Division, Sanofi Diagnostics Pasteur, Bayer Diagnostics and Centocor in different sales, sales management, global marketing and business development roles.

John Schilling Image

Insights and Strategies for Companion Diagnostic Commercialization

Monday, 27 October 2014 at 11:15

Add to Calendar ▼2014-10-27 11:15:002014-10-27 12:15:00Europe/LondonInsights and Strategies for Companion Diagnostic

The purpose of the talk is to inform and educate the audience about Companion Diagnostic Commercialization strategies from a pharmaceutical business perspective.  The presentation will also discuss key insights that are analyzed in the decision making process.  Also the talk will highlight certain levers that can be used to effectively commercialize a global companion diagnostics.

Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonCompanion